Multiple Sclerosis (MS)
Conditions
Brief summary
This single-center interventional study quasi-randomly allocated patients to a guided imagery or control intervention (positive journaling). Data were analyzed with treatment allocation masked.
Detailed description
Interventions: Participants were assigned in alternate order to 10 weekly 1-hour sessions Healing Light Guided Imagery or at-home positive journaling; drop-outs were replaced. Intervention Type: Behavioral Multiple sclerosis (MS) is an autoimmune disease that affects the brain and spinal cord (central nervous system). Because nerves in any part of the brain or spinal cord may be damaged, patients with multiple sclerosis can have symptoms in different parts of the body. Many Multiple Sclerosis patients suffer from depression, fatigue and anxiety in addition to physical symptoms. Drugs prescribed for MS have been shown to not improve these comorbid psychological symptoms. Researchers have shown that mindfulness-based training programs can help MS patients, but these therapies are highly resource demanding and taxing for those involved. Healing Light Guided Imagery (HLGI; supplementary materials) is a guided imagery therapy that simulates a self-hypnotic trance state that has been anecdotally shown to improve depression and fatigue in patients with MS in less time and with fewer support resources. The investigators plan to test whether HLGI can increase patient well-being.
Interventions
OTHERGuided Imagery
Guided Imagery meditation
OTHERJournaling
Keeping a journal
Sponsors
University of California, San Diego
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Healthy volunteers
No
Inclusion criteria
1. Diagnosis of Relapsing-Remitting Multiple Sclerosis 2. 18-70 years old 3. Able to read and write in English 4. Able to attend sessions at the UC San Diego School of Medicine * Age group: adult * Gender: both * Target enrollment: 20 Participant
Exclusion criteria
1. Severe depression (score of 31 or higher on the BDI) 2. Very high levels of fatigue (above an average of 6 on the FSS) 3. Low levels of mindfulness (below an average score of 2 on the FMI).
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Quality of Life (MS-QOL-54) | Change from baseline at 10 weeks | Quality of Life based on Multiple Sclerosis Quality of Life Instrument (MS-QOL-54) |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Mood (BDI-II) | Change from baseline at 10 weeks | Depressed mood based on the Beck Depression Inventory II (BDI-II) |
| Fatigue (FSS) | Change from baseline at 10 weeks | Fatigue levels based on the Fatigue Severity Scale (FSS) |
Countries
United States
Outcome results
None listed